Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human embryonic stem cells: technological challenges towards therapy.

Steve K W Oh1, Andre B H Choo

  • 1Stem Cell Group, Bioprocessing Technology Institute, Singapore. steve_oh@bti.a-star.edu.sg

Clinical and Experimental Pharmacology & Physiology
|May 17, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimizing effector functions of monoclonal antibodies via tailored N-glycan engineering using a dual landing pad CHO targeted integration platform.

Scientific reports·2023
Same author

A Scalable Suspension Platform for Generating High-Density Cultures of Universal Red Blood Cells from Human Induced Pluripotent Stem Cells.

Stem cell reports·2020
Same author

Dopamine transporter neuroimaging accurately assesses the maturation of dopamine neurons in a preclinical model of Parkinson's disease.

Stem cell research & therapy·2020
Same author

Influencing the Fate of Cardiac and Neural Stem Cell Differentiation Using Small Molecule Inhibitors of ALK5.

Stem cells translational medicine·2018
Same author

Immobilization of vitronectin-binding heparan sulfates onto surfaces to support human pluripotent stem cells.

Journal of biomedical materials research. Part B, Applied biomaterials·2017
Same author

Immature Midbrain Dopaminergic Neurons Derived from Floor-Plate Method Improve Cell Transplantation Therapy Efficacy for Parkinson's Disease.

Stem cells translational medicine·2017

Human embryonic stem cells (hESC) offer potential for treating diseases like Parkinson's and diabetes through tissue repair. Further research is needed to enhance hESC expansion and differentiation methods for therapeutic use.

Area of Science:

  • Stem cell biology
  • Regenerative medicine
  • Developmental biology

Background:

  • Human embryonic stem cells (hESC) are a promising source for cell types needed in tissue repair for diseases such as Parkinson's and diabetes.
  • hESC possess characteristics including surface antigen markers, transcription factors, and enzymes, enabling differentiation into three germ layers in vitro and in vivo.

Purpose of the Study:

  • To review the potential of hESC for disease treatment.
  • To highlight advancements in hESC culture conditions and identify key signaling pathways.
  • To discuss quality control measures and challenges in hESC therapeutic applications.

Main Methods:

  • Review of current literature on human embryonic stem cell culture and differentiation.
  • Analysis of signaling pathways involved in hESC self-renewal and differentiation.

Related Experiment Videos

  • Identification of essential quality control assays for therapeutic-grade hESC.

    • Main Results:

    • Feeder-free and serum-free culture conditions for hESC have been established.
    • Fibroblast growth factor-2 and transforming growth factor-b signaling pathways are crucial for maintaining hESC self-renewal and preventing differentiation.
    • Essential quality controls like karyotyping and immunogenicity assays are necessary for therapeutic hESC production.

    Conclusions:

    • Human embryonic stem cells hold significant therapeutic potential for various diseases.
    • While progress in hESC culture has been made, methods for expansion and differentiation require significant enhancement for clinical application.
    • Robust quality control measures are critical for the safe and effective therapeutic use of hESC.